safety_report_series_no.63_release of patients after radionuclide therapy

prev

next

out of 89

Download Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

Upload: jiar001

Post on 04-Apr-2018

215 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

TRANSCRIPT

7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

1/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

2/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

3/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

4/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

5/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

6/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

7/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

8/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

9/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

10/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

11/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

12/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

13/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

14/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

15/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

16/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

17/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

18/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

19/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

20/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

21/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

22/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

23/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

24/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

25/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

26/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

27/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

28/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

29/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

30/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

31/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

32/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

33/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

34/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

35/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

36/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

37/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

38/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

39/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

40/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

41/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

42/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

43/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

44/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

45/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

46/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

47/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

48/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

49/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

50/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

51/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

52/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

53/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

54/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

55/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

56/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

57/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

58/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

59/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

60/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

61/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

62/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

63/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

64/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

65/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

66/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

67/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

68/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

69/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

70/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

71/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

72/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

73/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

74/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

75/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

76/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

77/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

78/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

79/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

80/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

81/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

82/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

83/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

84/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

85/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

86/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

87/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

88/89
7/30/2019 Safety_Report_Series_No.63_Release of Patients After Radionuclide Therapy

89/89

Radionuclide Therapy: History, Present and Future Promiseamos3.aapm.org/abstracts/pdf/127-38218-416554-126355.pdfRadionuclide Therapy: History, Present and Future Promise Bennett S

Dosimetry of Radionuclide Therapy with 177Lu-octreotate - DiVA

Radionuclide Metabolic Therapy - European Association of Nuclear

Research Paper Targeted Radionuclide Therapy with … · Research Paper Targeted Radionuclide Therapy with A 177Lu-labeled ... In addition, coinfusion of untagged nanobodies with

Targeted Radionuclide Therapy: Proceedings of the 2 NCI ...jnm.snmjournals.org/content/early/2015/05/20/jnumed.115.159038.full.pdf · targeted radionuclide therapy (TRT)(1). Broad

Radionuclide therapy in nuclear medicine developments and ... · Klinik und Poliklinik für Nuklearmedizin Direktor: Prof. Dr. A. Buck Radionuclide therapy in nuclear medicine –

Bone targeted radionuclide therapy · Bone targeted radionuclide therapy ... •Refractory bone pain •+ve bone scan ... Microsoft PowerPoint - RSCSept07 - New Version.ppt

Peptide Receptor Radionuclide Therapy Martijn van.pdfRadiolabelled Somatostatin Analogue [177Lu-DOTA0,Tyr3]octreotate 179 8.2 Peptide Receptor Radionuclide Therapy with Radiolabelled

Peptide Receptor Radionuclide Therapy for Patients With ... · Peptide Receptor Radionuclide Therapy for Patients With Advanced Lung Carcinoids Boris G. Naraev,1 Robert A. Ramirez,2

Peptide receptor radionuclide therapy in

Bystander Effects elicited by targeted radionuclide therapy · targeted radionuclide therapy ... transfer of NAT gene, controlled by WAF1 or telomerase ... Direct + Indirect:incubate

Radionuclide Therapy Targeted Radionuclide therapy withncm-usa.com/wp-content/uploads/2018/11/radionuclide... · 2018-11-23 · of oxygenation or active cell proliferation • Very

a primer for radioimmunotherapy and radionuclide therapy

Radionuclide Metabolic Therapy - EANMnuclear medicine physicians, radiographers, nuclear medicine technologists and others. The book commences with background information about radionuclide

Clinical Trial Design and Scoring of Radionuclide Therapy ... · used in clinical trials of radionuclide agents, 2. comparison of normal tissue tolerance reported for radionuclides

177Lu-DOTA-octreotate Radionuclide Therapy of ...562732/FULLTEXT01.pdfGarske-Román, U. 2012. 177Lu-DOTA-octreotate Radionuclide Therapy of Neuroendocrine Tumours: Dosimetry-Based

Automated Software Framework for Voxelized Absorbed Dose Estimation in Radionuclide Therapy

PSMA-targeted radionuclide therapy of metastatic castration

New Strategies in Radionuclide Therapy for Hepatocellular ...lib.ugent.be › fulltxt › RUG01 › 000 › 906 › 010 › RUG01-000906010_20… · New Strategies in Radionuclide

New Horizons in radionuclide therapy - The Royal Society · PDF file · 2011-04-10•Interested in Radionuclide imaging and therapy using antibodies and peptides ... Dose Level FDG-PET

Peptide receptor radionuclide therapy controls

Anti-CD33 single chain antibody for radionuclide therapy of acute … · 2019-04-26 · Anti-CD33 single chain antibody for radionuclide therapy of acute myeloid leukaemia. Dr. Peter

Radionuclide Therapy by Stephen M. Karesh, Ph.D. Nuclear Medicine Department Loyola University Medical Center

University of Groningen Peptide receptor radionuclide therapy with ... · somatostatin analogues, interferon, chemotherapy, new targeted drugs and peptide receptor radionuclide therapy

in Diagnostic Imaging and Radionuclide Therapy: An ... Physics Staffing Needs . in Diagnostic Imaging and Radionuclide Therapy: An Activity Based Approach @ IAA MAN AT RPRTS No

Peptide receptor radionuclide therapy (PRRT) - …oncologypro.esmo.org/content/download/53281/983261/file/Preceptor... · Peptide receptor radionuclide therapy (PRRT) Prof. Dr. Christophe

Introduction to FAP Program and PTRT ... - Clovis OncologyIntroduction to Peptide-Targeted Radionuclide Therapy • Peptide-targeted radionuclide therapy (PTRT) involves a small amount

IAEA Safety Series No. 63-Release of Patients After Radionuclide Therapy

Radiobiology of radionuclide therapy - Human … · Radiobiology of radionuclide therapy Prof Sarah Baatout ... Head of the Radiobiology Unit, SCK•CEN Faculty of Biosciences Engineering,

Safety_Report_Series_No.61_Radiation Protection in Newer Medical Imaging Techniques_CT Colonography

Peptide Receptor Radionuclide Therapy in Grade 3 …jnm.snmjournals.org/content/60/3/377.full.pdf · 2019. 3. 1. · Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine

Targeted Radionuclide Therapy: Practicalities and Potentials · Targeted Radionuclide Therapy: Practicalities and Potentials ... I-125 60.0d auger 10nm At-211 7.2h alpha 65nm Lu-177

Neuroendocrine tumors: Peptide receptors radionuclide therapy … · 2016. 8. 1. · 1. Otte A, Jermann E, Behe M et al. DOTATOC - a powerful new tool for receptor-mediated radionuclide

EGFR and HER2 Targeting for Radionuclide-Based Imaging and ...172029/FULLTEXT01.pdf · EGFR and HER2 Targeting for Radionuclide-Based Imaging and Therapy Preclinical Studies ... SPMB

Targeted Radionuclide Therapy - EUR